Reset MapSuite 1120 111 River Street Hoboken, New Jersey, 07030 United StatesGenesis Research Group empowers life science companies to innovate differently by fundamentally transforming how they engage with research partners. We unite technology-enabled research, stakeholder insights (RPR®), data-agnostic real-world evidence expertise, and our innovative Flexible Integrated Team (FIT) engagement model to deliver scientifically rigorous and impactful evidence at an accelerated rate. By taking an integrated approach to evidence strategy, generation, optimization, and communication, we enable our global partners to anticipate and better address the evolving needs of payers, regulators, and other key stakeholders. Real-World Evidence and HEOR Leveraging extensive methodological expertise, technology-enablement, and broad experience across indications, we provide clients with robust, end-to-end real-world evidence (RWE) and health economics and outcomes research (HEOR) solutions. From study design to sophisticated modeling, AI-powered evidence synthesis, and HTA support, we deliver the global strategic advisory and impactful value demonstration required to navigate approval, achieve market access, and optimize patient outcomes. As the value of RWE to regulators, prescribers, and payers continues to grow, our clients increasingly rely on our deep therapeutic, methodological, and global dataset expertise. Our cross-functional team of 100+ RWE specialists across epidemiology, biostatistics, analytics, and pharmacoepidemiology and safety, and our data-agnostic approach—selecting fit-for-purpose data from all relevant sources—empowers us to provide the strategic guidance and scientific rigor needed to compete and win in highly competitive markets. Access and Pricing Navigating U.S. and global access and pricing in today's rapidly evolving environment demands robust evidence, rigorous analysis, and strategic precision. Genesis Research Group accelerates patient access to life science innovations through experience-based strategic counsel and deep insights delivered via our proprietary stakeholder engagement platform (RPR®) and global network of 3,500+ vetted payers, clinicians, and KOLs. Our team of 50+ industry experts provides clients with global strategic advisory, pricing strategy and analysis, and secondary research that creates meaningful impact through tailored, market-specific solutions delivered at unmatched speed and depth.
Morris Hills Turnpike, 4th Floor Short Hills, new jersey, 07078 United StatesGenesis Research Group empowers life science companies to innovate differently by fundamentally transforming how they engage with research partners. We unite technology-enabled research, stakeholder insights (RPR®), data-agnostic real-world evidence expertise, and our innovative Flexible Integrated Team (FIT) engagement model to deliver scientifically rigorous and impactful evidence at an accelerated rate. By taking an integrated approach to evidence strategy, generation, optimization, and communication, we enable our global partners to anticipate and better address the evolving needs of payers, regulators, and other key stakeholders. Real-World Evidence and HEOR Leveraging extensive methodological expertise, technology-enablement, and broad experience across indications, we provide clients with robust, end-to-end real-world evidence (RWE) and health economics and outcomes research (HEOR) solutions. From study design to sophisticated modeling, AI-powered evidence synthesis, and HTA support, we deliver the global strategic advisory and impactful value demonstration required to navigate approval, achieve market access, and optimize patient outcomes. As the value of RWE to regulators, prescribers, and payers continues to grow, our clients increasingly rely on our deep therapeutic, methodological, and global dataset expertise. Our cross-functional team of 100+ RWE specialists across epidemiology, biostatistics, analytics, and pharmacoepidemiology and safety, and our data-agnostic approach—selecting fit-for-purpose data from all relevant sources—empowers us to provide the strategic guidance and scientific rigor needed to compete and win in highly competitive markets. Access and Pricing Navigating U.S. and global access and pricing in today's rapidly evolving environment demands robust evidence, rigorous analysis, and strategic precision. Genesis Research Group accelerates patient access to life science innovations through experience-based strategic counsel and deep insights delivered via our proprietary stakeholder engagement platform (RPR®) and global network of 3,500+ vetted payers, clinicians, and KOLs. Our team of 50+ industry experts provides clients with global strategic advisory, pricing strategy and analysis, and secondary research that creates meaningful impact through tailored, market-specific solutions delivered at unmatched speed and depth.
Morris Hills Turnpike, 4th Floor Short Hills, NJ, 07078 United StatesGenesis Research Group empowers life science companies to innovate differently by fundamentally transforming how they engage with research partners. We unite technology-enabled research, stakeholder insights (RPR®), data-agnostic real-world evidence expertise, and our innovative Flexible Integrated Team (FIT) engagement model to deliver scientifically rigorous and impactful evidence at an accelerated rate. By taking an integrated approach to evidence strategy, generation, optimization, and communication, we enable our global partners to anticipate and better address the evolving needs of payers, regulators, and other key stakeholders. Real-World Evidence and HEOR Leveraging extensive methodological expertise, technology-enablement, and broad experience across indications, we provide clients with robust, end-to-end real-world evidence (RWE) and health economics and outcomes research (HEOR) solutions. From study design to sophisticated modeling, AI-powered evidence synthesis, and HTA support, we deliver the global strategic advisory and impactful value demonstration required to navigate approval, achieve market access, and optimize patient outcomes. As the value of RWE to regulators, prescribers, and payers continues to grow, our clients increasingly rely on our deep therapeutic, methodological, and global dataset expertise. Our cross-functional team of 100+ RWE specialists across epidemiology, biostatistics, analytics, and pharmacoepidemiology and safety, and our data-agnostic approach—selecting fit-for-purpose data from all relevant sources—empowers us to provide the strategic guidance and scientific rigor needed to compete and win in highly competitive markets. Access and Pricing Navigating U.S. and global access and pricing in today's rapidly evolving environment demands robust evidence, rigorous analysis, and strategic precision. Genesis Research Group accelerates patient access to life science innovations through experience-based strategic counsel and deep insights delivered via our proprietary stakeholder engagement platform (RPR®) and global network of 3,500+ vetted payers, clinicians, and KOLs. Our team of 50+ industry experts provides clients with global strategic advisory, pricing strategy and analysis, and secondary research that creates meaningful impact through tailored, market-specific solutions delivered at unmatched speed and depth.
Suite 1120 111 River Street Hoboken, NJ, 07030 United StatesGenesis Research Group empowers life science companies to innovate differently by fundamentally transforming how they engage with research partners. We unite technology-enabled research, stakeholder insights (RPR®), data-agnostic real-world evidence expertise, and our innovative Flexible Integrated Team (FIT) engagement model to deliver scientifically rigorous and impactful evidence at an accelerated rate. By taking an integrated approach to evidence strategy, generation, optimization, and communication, we enable our global partners to anticipate and better address the evolving needs of payers, regulators, and other key stakeholders. Real-World Evidence and HEOR Leveraging extensive methodological expertise, technology-enablement, and broad experience across indications, we provide clients with robust, end-to-end real-world evidence (RWE) and health economics and outcomes research (HEOR) solutions. From study design to sophisticated modeling, AI-powered evidence synthesis, and HTA support, we deliver the global strategic advisory and impactful value demonstration required to navigate approval, achieve market access, and optimize patient outcomes. As the value of RWE to regulators, prescribers, and payers continues to grow, our clients increasingly rely on our deep therapeutic, methodological, and global dataset expertise. Our cross-functional team of 100+ RWE specialists across epidemiology, biostatistics, analytics, and pharmacoepidemiology and safety, and our data-agnostic approach—selecting fit-for-purpose data from all relevant sources—empowers us to provide the strategic guidance and scientific rigor needed to compete and win in highly competitive markets. Access and Pricing Navigating U.S. and global access and pricing in today's rapidly evolving environment demands robust evidence, rigorous analysis, and strategic precision. Genesis Research Group accelerates patient access to life science innovations through experience-based strategic counsel and deep insights delivered via our proprietary stakeholder engagement platform (RPR®) and global network of 3,500+ vetted payers, clinicians, and KOLs. Our team of 50+ industry experts provides clients with global strategic advisory, pricing strategy and analysis, and secondary research that creates meaningful impact through tailored, market-specific solutions delivered at unmatched speed and depth.
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.